Income Statement
CORMEDIX INC.
CRMD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
311.71 | 43.47 | - | 0.07 | 0.19 | 0.24 | 0.28 | 0.33 | 0.22 | 0.21 | 0.19 | 0.00 | - | - |
|
Cost of Revenue
|
22.09 | 3.19 | 0.00 | 0.00 | 0.15 | 0.20 | 0.37 | 0.11 | -0.37 | -0.32 | -0.45 | -0.20 | - | - |
|
Gross Profit
|
275.75 | 40.28 | - | 0.06 | 0.04 | 0.03 | -0.09 | 0.21 | -0.14 | -0.11 | -0.26 | -0.20 | - | - |
|
Operating Expenses
|
125.61 | 62.64 | 48.96 | 30.69 | 29.48 | 27.26 | 20.92 | 33.14 | 24.62 | 16.55 | 8.65 | 4.72 | 3.04 | 7.25 |
|
Research & Development
|
19.33 | 3.94 | 13.16 | 10.68 | 13.13 | 13.38 | 11.05 | 24.49 | 15.74 | 6.28 | 1.32 | 1.23 | 1.19 | 4.10 |
|
Selling, General & Administrative
|
68.22 | 29.96 | 35.80 | 20.01 | 16.35 | 13.88 | 9.87 | 8.65 | 8.88 | 10.26 | 7.33 | 3.49 | 1.86 | 3.15 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
150.14 | -22.36 | -48.96 | -30.62 | -29.44 | -27.22 | -21.01 | -32.92 | -24.76 | -16.65 | -8.90 | -4.92 | -3.04 | -7.25 |
|
Non-Operating Income
|
-0.13 | 3.03 | - | -0.34 | 0.02 | -0.02 | 0.49 | - | - | - | - | 4.22 | 0.38 | -0.04 |
|
Interest Income
|
3.85 | 2.58 | 2.68 | 0.33 | 0.01 | 0.12 | 0.32 | 0.11 | 0.13 | 0.06 | 0.00 | 0.00 | 0.00 | 0.01 |
|
Interest Expense
|
- | - | 0.03 | 0.03 | 0.02 | 0.03 | 0.79 | 0.01 | 0.00 | 0.00 | 0.00 | 1.44 | 0.38 | - |
|
Other Non-Op Income / Expense
|
- | - | 2.62 | 0.34 | -0.02 | 0.02 | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
150.02 | -19.32 | - | -30.29 | -29.46 | -0.59 | -0.55 | -1.02 | -0.90 | -1.50 | -1.80 | -0.39 | -3.43 | -7.21 |
|
Income Tax Expense
|
-13.04 | -1.39 | - | -0.59 | -1.25 | -5.17 | -5.06 | - | - | - | - | 0.00 | 0.00 | -0.49 |
|
Non-Controlling Interest
|
- | - | - | - | 28.20 | - | - | - | - | - | - | - | - | - |
|
Net Income
|
163.06 | -17.93 | -46.34 | -29.70 | -28.21 | -22.03 | 16.43 | -33.01 | -24.64 | -18.19 | -20.45 | -9.13 | -3.43 | -6.71 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
150.14 | -22.36 | -48.96 | -30.62 | -29.44 | -27.22 | -21.01 | -32.92 | -24.76 | -16.65 | -8.90 | -4.92 | -3.04 | -7.25 |
|
Earnings Per Share (Basic)
|
2.25 | -0.30 | -0.91 | -0.74 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
2.04 | -0.30 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
0.07 | 58.87 | 50.90 | 40.27 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
0.08 | 58.87 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-0.09 | -17.93 | -46.33 | -29.71 | -28.23 | -22.02 | -16.43 | -32.99 | -24.62 | -18.22 | -20.35 | - | - | - |